Effect of medical castration on CYP3A4 enzyme activity using the erythromycin breath test Paul R. HutsonKurt OettelGeorge Wilding Original Article 09 October 2007 Pages: 373 - 377
The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel Fumio SakashitaShinji OsadaMitsuru Seishima Original Article 25 October 2007 Pages: 379 - 385
The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates Holly J. MeanyElizabeth FoxFrank M. Balis Original Article 12 October 2007 Pages: 387 - 392
Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study Dominique KoensgenDirk Stengelon behalf of the NOGGO (North-Eastern German Society of Gynecological Oncology) Study Group Ovarian Cancer Original Article 09 October 2007 Pages: 393 - 400
Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis Teppei MatsuiHidenari NagaiKazumasa Miki Original Article 12 October 2007 Pages: 401 - 406
Combination of all-trans retinoic acid and interferon-gamma upregulated p27kip1 and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells Ran ZhangNaren L. BanikSwapan K. Ray Original Article 25 October 2007 Pages: 407 - 416
Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts William C. ZamboniSandra StrychorJulie L. Eiseman Original Article 24 October 2007 Pages: 417 - 426
The first case of phenytoin intoxication associated with the concomitant use of phenytoin and TS-1, a combination preparation of tegafur, gimeracil, and oteracil potassium Aiko TsudaJunshin FujiyamaYasufumi Sawada Original Article 17 November 2007 Pages: 427 - 432
Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates Katherine E. WarrenCindy McCullyFrank M. Balis Original Article 25 October 2007 Pages: 433 - 437
The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia Lars MöllgårdStefan DenebergSören Lehmann Original Article 25 October 2007 Pages: 439 - 448
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors Kostas KalbakisPeriklis PappasDimitris Mavroudis Original Article 25 October 2007 Pages: 449 - 456
Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice Jan H. BeumerJulie L. EisemanMerrill J. Egorin Original Article 15 November 2007 Pages: 457 - 464
Phase II study of nedaplatin and irinotecan followed by gefitinib for elderly patients with unresectable non-small cell lung cancer Fumihiro OshitaKouzo YamadaKazumasa Noda Original Article 25 October 2007 Pages: 465 - 470
Formaldehyde-releasing prodrugs specifically affect cancer cells by depletion of intracellular glutathione and augmentation of reactive oxygen species Inesa LevovichAbraham NudelmanAda Rephaeli Original Article 21 November 2007 Pages: 471 - 482
In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines Marisa A. NavoJudith A. SmithLois M. Ramondetta Original Article 15 November 2007 Pages: 483 - 489
Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells Victor AdlerWilbur BowneMatthew R. Pincus Original Article 08 December 2007 Pages: 491 - 498
A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors Marwan G. FakihLakshmi PendyalaYoucef M. Rustum Original Article 08 November 2007 Pages: 499 - 508
4-Aryl-1,3,2-oxathiazolylium-5-olate: a novel GST inhibitor to release JNK and activate c-Jun for cancer therapy Huifei CuiJie ShenPeng George Wang Original Article 16 November 2007 Pages: 509 - 515
Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N 1 , N 11 diethylnorspermine Suzanne HectorRamakumar TummalaLakshmi Pendyala Original Article 07 November 2007 Pages: 517 - 527
Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients Kimie SaiYoshiro SaitoJun-ichi Sawada Original Article 08 November 2007 Pages: 529 - 537
Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma Yu-Hong LiFeng-Hua WangYou-Jian He Original Article 03 January 2008 Pages: 539 - 544
Influence of carboplatin infusion on osteosarcoma blood flow Gene R. DiRestaSean W. AikenJohn H. Healey Short Communication 12 October 2007 Pages: 545 - 549
Logistic regression analysis for febrile neutropenia (FN) induced by docetaxel in Japanese cancer patients Kazuhiro OzawaHironobu MinamiHitoshi Sato Short Communication 07 December 2007 Pages: 551 - 557